Abnormal Uterine Bleeding

1. Clinical profile and aetiological patterns of abnormal uterine bleeding in reproductive-age women: a cross-sectional observational study.
2. Correlation of endometrial thickness on transvaginal ultrasonography with endometrial histopathology in women with abnormal uterine bleeding undergoing clinically indicated endometrial sampling.
3. Diagnostic accuracy of transvaginal ultrasonography for detection of structural uterine causes in women with abnormal uterine bleeding using hysteroscopic findings as the reference standard.
4. Association of body mass index with endometrial abnormalities among women presenting with abnormal uterine bleeding: a cross-sectional analytical study.
5. Comparison of clinical characteristics and causes of abnormal uterine bleeding in reproductive-age and perimenopausal women.
6. Correlation of haemoglobin levels with severity and duration of menstrual bleeding in women with abnormal uterine bleeding.
7. Prevalence and predictors of endometrial hyperplasia among perimenopausal women with abnormal uterine bleeding undergoing clinically indicated endometrial sampling.
8. Comparative evaluation of transvaginal ultrasonography and hysteroscopy for detection of endometrial polyps in women with abnormal uterine bleeding.
9. Association between thyroid dysfunction and abnormal uterine bleeding patterns in reproductive-age women: a cross-sectional analytical study.
10. Clinical and ultrasonographic predictors of intracavitary uterine pathology in women presenting with abnormal uterine bleeding.
11. Correlation of Pictorial Blood Assessment Chart scores with haemoglobin and serum ferritin levels in women with heavy menstrual bleeding.
12. Comparison of menstrual characteristics and anaemia between women with structural and non-structural causes of abnormal uterine bleeding.
13. Diagnostic accuracy of endometrial thickness for prediction of significant endometrial pathology in perimenopausal women with abnormal uterine bleeding.
14. Association of parity, obesity, diabetes mellitus, and hypertension with endometrial pathology in perimenopausal abnormal uterine bleeding.
15. Spectrum of hysteroscopic findings in women with persistent abnormal uterine bleeding despite normal pelvic ultrasonography.
16. Agreement between preoperative ultrasonographic diagnosis and operative findings in women undergoing surgery for abnormal uterine bleeding.
17. Prevalence of iron deficiency and its association with menstrual blood-loss severity in women with heavy menstrual bleeding.
18. Comparison of office endometrial biopsy and hysteroscopy-directed biopsy findings in women with abnormal uterine bleeding undergoing both procedures for clinical indications.
19. Factors associated with need for surgical management during the index treatment episode among women presenting with abnormal uterine bleeding.
20. Clinicopathological correlation of abnormal uterine bleeding according to the International Federation of Gynecology and Obstetrics PALM-COEIN classification: a cross-sectional study.

Uterine Fibroids

21. Clinical and ultrasonographic profile of women with uterine leiomyomas: a cross-sectional observational study.
22. Association of fibroid size, number, and location with menstrual blood-loss severity in women with symptomatic uterine leiomyomas.
23. Correlation of uterine leiomyoma burden on ultrasonography with haemoglobin and serum ferritin levels.
24. Comparison of clinical presentation of submucosal, intramural, and subserosal uterine leiomyomas.
25. Diagnostic accuracy of transvaginal ultrasonography for submucosal leiomyomas using hysteroscopic findings as the reference standard.
26. Association between body mass index and number, size, and symptom profile of uterine leiomyomas.
27. Prevalence and predictors of anaemia among women with symptomatic uterine leiomyomas.
28. Comparison of ultrasonographic findings with intraoperative findings in women undergoing surgery for uterine leiomyomas.
29. Correlation of preoperative ultrasonographic fibroid mapping with operative difficulty during myomectomy.
30. Association of leiomyoma characteristics with dysmenorrhea and pelvic pain severity: a cross-sectional analytical study.
31. Clinical and imaging predictors of blood transfusion requirement during hospitalisation for symptomatic uterine leiomyomas.
32. Comparison of perioperative outcomes of laparoscopic and open myomectomy in appropriately selected women: a prospective observational study.
33. Comparison of perioperative outcomes of total laparoscopic hysterectomy and abdominal hysterectomy for symptomatic leiomyomas.
34. Predictors of conversion to laparotomy during planned laparoscopic surgery for uterine leiomyomas: a retrospective observational study.
35. Correlation between preoperative uterine size assessed clinically and ultrasonographically in women with uterine leiomyomas.
36. Association of submucosal leiomyoma characteristics with degree of abnormal uterine bleeding.
37. Histopathological spectrum of hysterectomy specimens operated for presumed uterine leiomyomas.
38. Frequency and determinants of coexisting adenomyosis among women undergoing hysterectomy for uterine leiomyomas.
39. Comparison of preoperative haemoglobin optimization status with perioperative transfusion requirements in women undergoing surgery for fibroids.
40. Factors associated with prolonged operative time during myomectomy for uterine leiomyomas: a prospective observational study.

Adenomyosis

41. Clinical and transvaginal ultrasonographic profile of women with adenomyosis: a cross-sectional observational study.
42. Association of ultrasonographic features of adenomyosis with severity of dysmenorrhea.
43. Correlation of ultrasonographic extent of adenomyosis with menstrual blood-loss severity and anaemia.
44. Diagnostic accuracy of transvaginal ultrasonography for adenomyosis using hysterectomy histopathology as the reference standard in women undergoing clinically indicated hysterectomy.
45. Comparison of symptom profiles in women with adenomyosis and uterine leiomyomas.
46. Prevalence of coexisting uterine leiomyomas among women with sonographically diagnosed adenomyosis.
47. Association of parity and previous caesarean delivery with adenomyosis: a case-control study.
48. Correlation of uterine volume with pain and bleeding symptoms in women with adenomyosis.
49. Agreement between clinical, ultrasonographic, and histopathological diagnosis of adenomyosis.
50. Association between adenomyosis and iron-deficiency anaemia among women presenting with heavy menstrual bleeding.
51. Comparison of ultrasonographic characteristics of focal and diffuse adenomyosis.
52. Clinical predictors of adenomyosis among women presenting with dysmenorrhea and heavy menstrual bleeding.
53. Relationship between myometrial cysts, heterogeneous myometrium, and junctional-zone abnormalities on imaging and histopathological diagnosis of adenomyosis.
54. Frequency of incidental adenomyosis in hysterectomy specimens and its preoperative clinical predictors.
55. Comparison of perioperative characteristics of hysterectomy in women with and without adenomyosis.
56. Association of adenomyosis severity on ultrasonography with chronic pelvic pain.
57. Correlation between uterine tenderness on bimanual examination and ultrasonographic evidence of adenomyosis.
58. Comparison of transabdominal and transvaginal ultrasonographic assessment of adenomyosis in clinically suspected cases.
59. Clinical and histopathological characteristics of adenomyosis with coexisting endometriosis.
60. Factors associated with severe symptom burden among women with sonographically diagnosed adenomyosis: a cross-sectional analytical study.

Endometriosis

61. Clinical profile and anatomical distribution of endometriosis among women undergoing clinically indicated laparoscopy.
62. Correlation of preoperative pain severity with laparoscopic stage of endometriosis.
63. Diagnostic accuracy of transvaginal ultrasonography for ovarian endometriomas using operative findings as the reference standard.
64. Association of endometrioma size and bilaterality with ovarian reserve parameters in women with infertility.
65. Comparison of clinical and ultrasonographic characteristics of endometriomas and other benign ovarian cysts.
66. Association of dysmenorrhea severity with deep endometriotic lesions identified during clinically indicated surgery.
67. Correlation of serum cancer antigen 125 levels with laparoscopic stage of endometriosis in women in whom the test is clinically indicated.
68. Clinical predictors of moderate-to-severe endometriosis among women undergoing laparoscopy for chronic pelvic pain.
69. Comparison of pelvic examination findings with laparoscopic findings in suspected endometriosis.
70. Association of infertility characteristics with anatomical extent of endometriosis at laparoscopy.
71. Prevalence of endometriosis among women undergoing laparoscopy for chronic pelvic pain.
72. Comparative perioperative outcomes of laparoscopic cystectomy for endometriomas and other benign ovarian cysts.
73. Correlation of ultrasonographic endometrioma characteristics with operative findings.
74. Association of endometriosis with reduced antral follicle count in women evaluated for infertility.
75. Diagnostic performance of sliding sign on transvaginal ultrasonography for prediction of posterior compartment adhesions in suspected endometriosis.
76. Comparison of symptom profiles in women with superficial and advanced endometriosis at laparoscopy.
77. Factors associated with dense pelvic adhesions during surgery for endometriosis.
78. Correlation of chronic pelvic pain duration with laparoscopic disease distribution in endometriosis.
79. Histopathological confirmation rate of visually suspected endometriotic lesions excised during clinically indicated surgery.
80. Association between endometriosis and coexisting adenomyosis among women undergoing pelvic ultrasonography for gynecological symptoms.

Polycystic Ovary Syndrome

81. Clinical, metabolic, and ultrasonographic profile of women with polycystic ovary syndrome: a cross-sectional observational study.
82. Association of body mass index with menstrual irregularity and hyperandrogenic features in polycystic ovary syndrome.
83. Correlation of waist circumference with fasting glucose and lipid profile in women with polycystic ovary syndrome.
84. Prevalence of impaired glucose regulation among women with polycystic ovary syndrome attending a gynecology clinic.
85. Association of acanthosis nigricans with metabolic abnormalities in women with polycystic ovary syndrome.
86. Correlation of antral follicle count with clinical and biochemical hyperandrogenism in polycystic ovary syndrome.
87. Comparison of metabolic profiles of lean and overweight women with polycystic ovary syndrome.
88. Association between menstrual-cycle pattern and endometrial thickness in women with polycystic ovary syndrome.
89. Prevalence and determinants of anaemia and micronutrient-related haematological abnormalities among women with polycystic ovary syndrome.
90. Correlation of Ferriman-Gallwey score with serum androgen levels in women evaluated for polycystic ovary syndrome.
91. Association of infertility duration with body mass index and ovarian morphology in women with polycystic ovary syndrome.
92. Comparison of clinical features in women with polycystic ovary syndrome with and without metabolic syndrome.
93. Prevalence of non-alcoholic fatty liver detected incidentally on clinically indicated ultrasonography among women with polycystic ovary syndrome and its association with metabolic risk factors.
94. Association of thyroid dysfunction with menstrual irregularity among women evaluated for polycystic ovary syndrome.
95. Correlation between ovarian volume and markers of hyperandrogenism in polycystic ovary syndrome.
96. Prevalence and predictors of endometrial thickening among women with chronic anovulation due to polycystic ovary syndrome.
97. Comparison of fasting glucose and glycated haemoglobin abnormalities in women with polycystic ovary syndrome.
98. Association between acne severity and biochemical hyperandrogenism in women with polycystic ovary syndrome.
99. Clinical predictors of metabolic syndrome among reproductive-age women with polycystic ovary syndrome.
100. Relationship between duration of menstrual irregularity and metabolic abnormalities in women with polycystic ovary syndrome.

Infertility

101. Clinical and aetiological profile of female infertility in couples attending a tertiary-care infertility clinic: a cross-sectional study.
102. Comparison of ovarian reserve parameters in women with primary and secondary infertility.
103. Correlation of age with anti-Müllerian hormone level and antral follicle count among women undergoing infertility evaluation.
104. Diagnostic agreement between hysterosalpingography and laparoscopy with chromopertubation for tubal patency in women undergoing both for clinical indications.
105. Spectrum of hysteroscopic abnormalities among women undergoing evaluation for infertility.
106. Association of body mass index with ovarian reserve parameters in infertile women.
107. Prevalence of uterine cavity abnormalities among women with infertility undergoing clinically indicated hysteroscopy.
108. Correlation of endometrial thickness with menstrual-cycle characteristics in women undergoing infertility evaluation.
109. Association between duration of infertility and pelvic pathology detected at laparoscopy.
110. Comparison of hysterosalpingographic findings in primary and secondary infertility.
111. Prevalence and pattern of ovulatory disorders among women presenting with infertility.
112. Association of polycystic ovary syndrome phenotype with infertility characteristics in women attending an infertility clinic.
113. Correlation of semen parameters with female-factor abnormalities in couples undergoing infertility evaluation.
114. Diagnostic accuracy of transvaginal ultrasonography for detection of uterine abnormalities using hysteroscopy as the reference standard.
115. Prevalence and predictors of endometriosis among infertile women undergoing clinically indicated laparoscopy.
116. Comparison of ovarian reserve parameters in women with and without endometriomas presenting with infertility.
117. Association between previous pelvic surgery and tubal-factor infertility: a case-control study.
118. Correlation of hysterosalpingographic tubal findings with pelvic adhesions at laparoscopy.
119. Clinical predictors of abnormal hysteroscopic findings among women with infertility.
120. Aetiological patterns and associated factors in secondary infertility among women attending a tertiary-care gynecology clinic.

Ovarian Cysts and Benign Adnexal Masses

121. Clinical and ultrasonographic profile of benign adnexal masses in reproductive-age women.
122. Diagnostic performance of the International Ovarian Tumour Analysis Simple Rules in characterization of adnexal masses using histopathology as the reference standard in operated patients.
123. Correlation of ultrasonographic morphology with histopathology in surgically managed benign ovarian masses.
124. Comparison of clinical and ultrasonographic characteristics of endometriomas, dermoid cysts, and serous cystadenomas.
125. Association of adnexal-mass size with risk of torsion among women undergoing emergency surgery: a case-control study.
126. Clinical predictors of ovarian torsion in women presenting with an adnexal mass and acute pelvic pain.
127. Diagnostic accuracy of ultrasonography with color Doppler for ovarian torsion using operative findings as the reference standard.
128. Comparison of perioperative outcomes of laparoscopic and open surgery for benign ovarian cysts.
129. Factors associated with conversion from laparoscopy to laparotomy during surgery for benign adnexal masses.
130. Correlation between preoperative ultrasonographic size and operative size of ovarian cysts.
131. Association between menopausal status and morphological characteristics of benign adnexal masses.
132. Histopathological spectrum of surgically removed benign ovarian tumours in a tertiary-care hospital.
133. Diagnostic accuracy of Risk of Malignancy Index in women with adnexal masses undergoing surgery.
134. Association of serum cancer antigen 125 with benign gynecological conditions presenting as adnexal masses.
135. Comparison of clinical presentation of torsion and non-torsion adnexal masses.
136. Factors associated with ovarian preservation during emergency surgery for adnexal torsion.
137. Correlation of Doppler vascularity with operative viability of torsed adnexa.
138. Frequency and predictors of incidental adnexal masses detected during pelvic ultrasonography for gynecological complaints.
139. Comparison of ultrasonographic and intraoperative diagnosis of adnexal masses.
140. Perioperative complications and predictors of difficult laparoscopic cystectomy for benign ovarian masses.

Cervical Cancer Screening and Precancerous Cervical Lesions

141. Prevalence of abnormal cervical cytology among women attending a gynecology clinic for cervical cancer screening.
142. Diagnostic accuracy of visual inspection with acetic acid for detection of high-grade cervical lesions using histopathology as the reference standard.
143. Correlation of cervical cytology with colposcopic findings in women with abnormal screening tests.
144. Diagnostic agreement between cervical cytology and colposcopy-directed biopsy in women with suspected cervical precancerous lesions.
145. Prevalence and predictors of high-grade cervical lesions among women with abnormal cervical cytology.
146. Association of age, parity, and smoking exposure with abnormal cervical cytology: a cross-sectional analytical study.
147. Comparison of visual inspection with acetic acid and cervical cytology for detection of cervical precancerous lesions.
148. Colposcopic profile of women with persistent cervical discharge and an unhealthy cervix.
149. Diagnostic performance of Reid Colposcopic Index for prediction of high-grade cervical intraepithelial lesions.
150. Correlation between transformation-zone type and adequacy of colposcopic examination.
151. Prevalence of cervical intraepithelial neoplasia among women with postcoital bleeding undergoing clinically indicated evaluation.
152. Clinical predictors of significant cervical pathology among women with an unhealthy cervix.
153. Comparison of cytological and histopathological findings in women undergoing colposcopy-directed cervical biopsy.
154. Association of reproductive factors with cervical intraepithelial neoplasia: a case-control study.
155. Diagnostic accuracy of colposcopic impression for high-grade cervical intraepithelial neoplasia.
156. Spectrum of histopathological findings among women undergoing biopsy for abnormal cervical screening results.
157. Prevalence of abnormal cervical screening findings among perimenopausal women attending gynecology services.
158. Association of vaginal and cervical symptoms with abnormal cervical screening results.
159. Factors associated with unsatisfactory cervical cytology and colposcopy in women undergoing screening.
160. Concordance of visual inspection with acetic acid, cervical cytology, colposcopy, and histopathology in detection of cervical precancerous lesions.

Cervical Cancer

161. Clinical and pathological profile of women newly diagnosed with carcinoma cervix at a tertiary-care hospital.
162. Association of presenting symptoms with clinical stage at diagnosis in carcinoma cervix.
163. Correlation of clinical examination and magnetic resonance imaging findings in local staging of carcinoma cervix among women undergoing clinically indicated imaging.
164. Diagnostic accuracy of magnetic resonance imaging for parametrial involvement in carcinoma cervix using operative or pathological findings where applicable.
165. Association of pretreatment haemoglobin levels with clinical stage and tumour characteristics in carcinoma cervix.
166. Prevalence and predictors of obstructive uropathy among women presenting with carcinoma cervix.
167. Correlation of tumour size on clinical examination with imaging measurements in carcinoma cervix.
168. Association of socioeconomic and reproductive characteristics with advanced-stage presentation of carcinoma cervix: a case-control study.
169. Histopathological spectrum and stage distribution of carcinoma cervix in a tertiary-care gynecologic oncology unit.
170. Clinical predictors of lymph-node enlargement on imaging in carcinoma cervix.
171. Comparison of clinical and imaging assessment of parametrial involvement in carcinoma cervix.
172. Prevalence of anaemia and its determinants at presentation among women with carcinoma cervix.
173. Pattern of urinary tract involvement among women with locally advanced carcinoma cervix undergoing routine evaluation.
174. Association of delay from onset of symptoms to diagnosis with stage of carcinoma cervix.
175. Comparison of symptom profile in early-stage and locally advanced carcinoma cervix.
176. Factors associated with need for blood transfusion during initial hospitalisation among women with carcinoma cervix.
177. Correlation of histological type and grade with stage at diagnosis in carcinoma cervix.
178. Diagnostic utility of pelvic examination findings for prediction of advanced local disease in carcinoma cervix.
179. Prevalence and determinants of vaginal bleeding-related anaemia among women newly diagnosed with carcinoma cervix.
180. Clinical and imaging characteristics associated with pelvic lymphadenopathy in carcinoma cervix.

Endometrial Hyperplasia and Endometrial Cancer

181. Clinical profile and risk factors of endometrial hyperplasia among women undergoing endometrial sampling for abnormal uterine bleeding.
182. Correlation of transvaginal ultrasonographic endometrial thickness with histopathological findings in postmenopausal bleeding.
183. Diagnostic accuracy of endometrial thickness for detection of endometrial malignancy in women with postmenopausal bleeding.
184. Association of obesity, diabetes mellitus, and hypertension with endometrial hyperplasia and carcinoma: a case-control study.
185. Prevalence of significant endometrial pathology among women with postmenopausal bleeding.
186. Comparison of endometrial histopathology in obese and non-obese women with abnormal uterine bleeding.
187. Diagnostic agreement between office endometrial biopsy and hysterectomy histopathology in women undergoing surgery for endometrial pathology.
188. Clinical predictors of atypical endometrial hyperplasia among perimenopausal women with abnormal uterine bleeding.
189. Correlation between ultrasonographic endometrial morphology and histopathological diagnosis in women with abnormal uterine bleeding.
190. Prevalence of coexisting endometrial carcinoma in women undergoing hysterectomy after a diagnosis of atypical endometrial hyperplasia.
191. Association of polycystic ovary syndrome and chronic anovulation with endometrial hyperplasia in reproductive-age women.
192. Comparison of clinical characteristics of endometrial hyperplasia with and without atypia.
193. Diagnostic accuracy of transvaginal ultrasonography for intracavitary endometrial lesions using hysteroscopy as the reference standard.
194. Association of parity and menopausal status with histological patterns of endometrial pathology.
195. Clinical and pathological profile of women with newly diagnosed endometrial carcinoma.
196. Correlation of preoperative imaging with surgical staging findings in endometrial carcinoma.
197. Association of tumour grade with depth of myometrial invasion in surgically managed endometrial carcinoma.
198. Predictors of significant endometrial pathology among women with recurrent postmenopausal bleeding.
199. Comparison of endometrial thickness between benign, premalignant, and malignant histopathological groups.
200. Factors associated with inadequate endometrial sampling in women evaluated for abnormal uterine bleeding.

Ovarian Cancer and Suspicious Adnexal Masses

201. Clinical, ultrasonographic, and pathological profile of women operated for suspected ovarian malignancy.
202. Diagnostic performance of Risk of Malignancy Index for differentiating benign and malignant adnexal masses.
203. Diagnostic accuracy of International Ovarian Tumour Analysis Simple Rules for prediction of ovarian malignancy using histopathology as the reference standard.
204. Comparison of Risk of Malignancy Index and International Ovarian Tumour Analysis Simple Rules in characterization of adnexal masses.
205. Correlation of serum cancer antigen 125 levels with stage and histological type of epithelial ovarian cancer.
206. Association of ultrasonographic morphology with histopathological diagnosis in malignant and benign ovarian masses.
207. Clinical predictors of malignancy among postmenopausal women presenting with adnexal masses.
208. Comparison of symptom profiles in benign and malignant ovarian tumours.
209. Association of ascites and ultrasonographic solid components with malignant ovarian histopathology.
210. Diagnostic accuracy of color Doppler vascularity characteristics for discrimination of benign and malignant adnexal masses.
211. Clinical and pathological profile of epithelial ovarian cancers at initial diagnosis.
212. Correlation of preoperative imaging assessment with intraoperative extent of disease in ovarian malignancy.
213. Association of menopausal status with histological spectrum of ovarian tumours.
214. Predictors of malignant histopathology among women undergoing surgery for complex adnexal masses.
215. Comparison of preoperative and postoperative histopathological diagnosis of presumed benign adnexal masses.
216. Prevalence of anaemia and hypoalbuminemia among women presenting with suspected ovarian malignancy and their association with disease burden.
217. Correlation between ovarian-mass size and histological type among surgically managed ovarian tumours.
218. Clinical predictors of ascites among women with malignant ovarian tumours.
219. Concordance between preoperative risk stratification and final histopathology in women with adnexal masses.
220. Spectrum of unexpected malignant and borderline pathology among adnexal masses operated with a preoperative diagnosis of benign disease.

Pelvic Organ Prolapse

221. Clinical profile and risk factors of pelvic organ prolapse among women attending a gynecology clinic.
222. Association of parity, mode of delivery, and menopausal status with severity of pelvic organ prolapse.
223. Correlation of Pelvic Organ Prolapse Quantification stage with urinary symptoms in women with pelvic organ prolapse.
224. Association of body mass index with stage and symptom severity of pelvic organ prolapse.
225. Prevalence and predictors of stress urinary incontinence among women with pelvic organ prolapse.
226. Comparison of urinary symptoms in women with anterior-compartment and apical prolapse.
227. Clinical predictors of advanced-stage pelvic organ prolapse in postmenopausal women.
228. Association of chronic constipation and chronic cough with pelvic organ prolapse: a case-control study.
229. Correlation of pelvic-floor symptom scores with objective prolapse stage.
230. Comparison of perioperative outcomes of vaginal hysterectomy with pelvic-floor repair and uterus-preserving prolapse surgery in appropriately selected women.
231. Frequency and predictors of occult stress urinary incontinence in women with advanced pelvic organ prolapse undergoing clinically indicated assessment.
232. Association between duration of prolapse symptoms and Pelvic Organ Prolapse Quantification stage.
233. Comparison of clinical characteristics of premenopausal and postmenopausal women with pelvic organ prolapse.
234. Factors associated with difficult vaginal hysterectomy in women undergoing surgery for pelvic organ prolapse.
235. Correlation between genital hiatus measurements and prolapse stage.
236. Prevalence of urinary tract infections among women presenting with advanced pelvic organ prolapse.
237. Association of levator ani muscle strength on clinical assessment with severity of pelvic organ prolapse.
238. Comparison of immediate perioperative outcomes between women undergoing prolapse surgery with and without concomitant anti-incontinence procedures.
239. Predictors of postoperative urinary retention during the index hospitalisation after pelvic organ prolapse surgery.
240. Pattern of compartment-specific defects among women with pelvic organ prolapse using Pelvic Organ Prolapse Quantification assessment.

Urinary Incontinence and Female Urology

241. Prevalence and clinical profile of urinary incontinence among women attending a gynecology outpatient clinic.
242. Comparison of risk factors in women with stress, urgency, and mixed urinary incontinence.
243. Association of parity and mode of delivery with stress urinary incontinence: a case-control study.
244. Correlation of cough stress test findings with symptom severity in women with stress urinary incontinence.
245. Diagnostic agreement between clinical assessment and urodynamic diagnosis in women undergoing clinically indicated urodynamic testing for urinary incontinence.
246. Association of body mass index with severity of stress urinary incontinence.
247. Prevalence of urinary incontinence among women with pelvic organ prolapse.
248. Comparison of urinary symptoms before and immediately after prolapse reduction during clinical evaluation.
249. Clinical predictors of urodynamic stress incontinence among symptomatic women.
250. Association of menopausal status with type and severity of urinary incontinence.
251. Correlation of postvoid residual urine volume with pelvic organ prolapse stage.
252. Prevalence and predictors of recurrent urinary tract symptoms among women with pelvic-floor disorders.
253. Comparison of symptom scores between women with stress and mixed urinary incontinence.
254. Association of previous pelvic surgery with urinary incontinence: a case-control study.
255. Diagnostic performance of bladder diary parameters for differentiation of stress and urgency-predominant urinary incontinence.
256. Clinical predictors of elevated postvoid residual urine among women with pelvic organ prolapse.
257. Comparison of perioperative outcomes of different routinely used mid-urethral sling approaches for stress urinary incontinence.
258. Factors associated with immediate postoperative voiding dysfunction after surgery for stress urinary incontinence.
259. Correlation of pelvic-floor muscle strength with urinary-incontinence symptom severity.
260. Prevalence and associated factors of overactive bladder symptoms among perimenopausal and postmenopausal women attending gynecology services.

Menopause

261. Clinical profile and prevalence of menopausal symptoms among women attending a gynecology clinic.
262. Association of body mass index with severity of menopausal symptoms.
263. Correlation of menopausal symptom severity with duration since menopause.
264. Prevalence and predictors of genitourinary syndrome of menopause among postmenopausal women.
265. Association of vaginal pH with symptoms and clinical findings of genitourinary syndrome of menopause.
266. Comparison of menopausal symptom profiles in early and late postmenopausal women.
267. Prevalence of abnormal uterine bleeding etiologies among perimenopausal women.
268. Association of metabolic risk factors with menopausal status in women attending gynecology services.
269. Correlation of waist circumference with blood pressure, fasting glucose, and lipid profile in postmenopausal women.
270. Prevalence of pelvic organ prolapse and urinary incontinence among postmenopausal women attending a gynecology clinic.
271. Association between parity and pelvic-floor symptoms among postmenopausal women.
272. Clinical and ultrasonographic evaluation of endometrial abnormalities in postmenopausal women presenting with bleeding.
273. Prevalence and predictors of vulvovaginal atrophic changes among postmenopausal women.
274. Comparison of vaginal symptoms in women with natural menopause and surgically induced menopause.
275. Association of age at menopause with metabolic risk factors: a cross-sectional analytical study.
276. Correlation of symptom-based menopausal scores with sleep-related complaints in postmenopausal women.
277. Prevalence of cervical screening abnormalities among postmenopausal women attending gynecology clinics.
278. Association of diabetes mellitus with vulvovaginal symptoms in postmenopausal women.
279. Clinical predictors of significant endometrial pathology among postmenopausal women with bleeding.
280. Spectrum of gynecological disorders among postmenopausal women attending a tertiary-care hospital.

Pelvic Inflammatory Disease

281. Clinical profile and aetiological patterns of pelvic inflammatory disease among reproductive-age women.
282. Correlation of clinical severity with ultrasonographic findings in pelvic inflammatory disease.
283. Prevalence and predictors of tubo-ovarian abscess among women admitted with pelvic inflammatory disease.
284. Comparison of clinical characteristics of pelvic inflammatory disease with and without tubo-ovarian abscess.
285. Association of intrauterine contraceptive device use with clinical presentation of pelvic inflammatory disease: a case-control study.
286. Diagnostic accuracy of transvaginal ultrasonography for tubo-ovarian abscess using operative or clinical composite diagnosis as the reference standard.
287. Correlation of leucocyte count and C-reactive protein with clinical severity of pelvic inflammatory disease.
288. Factors associated with need for surgical intervention during hospitalisation for tubo-ovarian abscess.
289. Comparison of short-term inpatient outcomes in women with uncomplicated pelvic inflammatory disease and tubo-ovarian abscess.
290. Clinical predictors of prolonged hospital stay in women admitted with pelvic inflammatory disease.
291. Association of previous pelvic inflammatory disease with tubal abnormalities among women undergoing infertility evaluation.
292. Prevalence of pelvic adhesions among women with a history of pelvic inflammatory disease undergoing clinically indicated laparoscopy.
293. Correlation of hysterosalpingographic abnormalities with previous pelvic inflammatory disease in infertile women.
294. Clinical and ultrasonographic predictors of tubo-ovarian abscess rupture at surgery.
295. Comparison of laboratory inflammatory markers in mild and severe pelvic inflammatory disease.
296. Association of diabetes mellitus with severity and complications of pelvic inflammatory disease.
297. Spectrum of adnexal findings on ultrasonography in women with clinically diagnosed pelvic inflammatory disease.
298. Factors associated with failure of initial conservative management during the index admission for tubo-ovarian abscess.
299. Comparison of clinical diagnosis with laparoscopic findings in women undergoing surgery for suspected pelvic inflammatory disease.
300. Association between symptom duration before admission and severity of pelvic inflammatory disease.

Vaginal and Vulval Disorders

301. Clinical and microbiological profile of symptomatic vaginal discharge among reproductive-age women.
302. Prevalence and associated factors of vulvovaginal candidiasis among women presenting with vaginal discharge.
303. Comparison of clinical diagnosis with microscopy-based diagnosis in common causes of vaginitis.
304. Diagnostic accuracy of vaginal pH and bedside clinical findings for bacterial vaginosis using standard diagnostic criteria as the reference.
305. Association of diabetes mellitus with recurrent vulvovaginal candidiasis: a case-control study.
306. Clinical profile and aetiological patterns of vulval pruritus among women attending a gynecology clinic.
307. Prevalence of vulval dermatoses among women undergoing clinically indicated vulval examination and biopsy.
308. Correlation of clinical diagnosis with histopathology in women undergoing biopsy for persistent vulval lesions.
309. Clinical predictors of premalignant or malignant pathology among women with persistent vulval lesions.
310. Comparison of vaginal infection patterns in reproductive-age and postmenopausal women.
311. Association of contraceptive method with symptomatic vaginal infections: a cross-sectional analytical study.
312. Prevalence of mixed vaginal infections among women with persistent vaginal discharge.
313. Comparison of clinical characteristics of bacterial vaginosis and vulvovaginal candidiasis.
314. Association of antibiotic exposure with vulvovaginal candidiasis among reproductive-age women.
315. Prevalence and clinical profile of Bartholin gland cysts and abscesses among women attending gynecology emergency services.
316. Comparison of clinical and operative characteristics of primary and recurrent Bartholin gland abscesses.
317. Spectrum of benign vulval lesions among women presenting to a tertiary gynecology clinic.
318. Association between menopausal status and chronic vulval symptoms.
319. Clinical and histopathological correlation of vulval leukoplakic lesions undergoing clinically indicated biopsy.
320. Predictors of significant vulval pathology among women presenting with chronic vulval itching or lesions.

Dysmenorrhea and Chronic Pelvic Pain

321. Prevalence and clinical characteristics of dysmenorrhea among reproductive-age women attending gynecology services.
322. Association of dysmenorrhea severity with ultrasonographic pelvic abnormalities.
323. Comparison of clinical characteristics of primary and secondary dysmenorrhea.
324. Prevalence of endometriosis among women undergoing laparoscopy for chronic pelvic pain.
325. Correlation of pain severity with laparoscopic findings in women with chronic pelvic pain.
326. Association of adenomyosis with chronic pelvic pain among women undergoing transvaginal ultrasonography.
327. Clinical predictors of abnormal laparoscopic findings in women with chronic pelvic pain.
328. Comparison of pelvic examination and ultrasonographic findings in women with chronic pelvic pain.
329. Association of previous pelvic surgery with chronic pelvic pain: a case-control study.
330. Prevalence and patterns of pelvic adhesions among women undergoing clinically indicated laparoscopy for chronic pelvic pain.
331. Correlation of dysmenorrhea severity with endometriosis stage in surgically confirmed disease.
332. Association of uterine leiomyoma location with dysmenorrhea and pelvic pressure symptoms.
333. Diagnostic accuracy of transvaginal ultrasonography for detection of structural causes of secondary dysmenorrhea.
334. Clinical and imaging profile of women with chronic pelvic pain and normal pelvic examination.
335. Comparison of pain characteristics in endometriosis, adenomyosis, and pelvic inflammatory disease.
336. Factors associated with severe dysmenorrhea among women with sonographically diagnosed adenomyosis.
337. Correlation of duration of chronic pelvic pain with extent of pelvic adhesions at laparoscopy.
338. Clinical predictors of endometriosis among women presenting primarily with dysmenorrhea.
339. Prevalence of multiple coexisting gynecological causes among women evaluated for chronic pelvic pain.
340. Agreement between preoperative clinical diagnosis and laparoscopic diagnosis in women with chronic pelvic pain.

Hysteroscopy

341. Spectrum of hysteroscopic findings among women undergoing evaluation for abnormal uterine bleeding.
342. Diagnostic accuracy of transvaginal ultrasonography for intracavitary uterine lesions using hysteroscopy as the reference standard.
343. Correlation of hysteroscopic appearance with histopathology in women undergoing endometrial biopsy for clinically indicated intrauterine lesions.
344. Comparison of transvaginal ultrasonography and hysteroscopy for detection of endometrial polyps.
345. Diagnostic performance of hysteroscopy for submucosal leiomyomas using operative and histopathological findings as reference standards.
346. Prevalence of intrauterine abnormalities among women undergoing hysteroscopy for infertility evaluation.
347. Comparison of hysteroscopic findings in primary and secondary infertility.
348. Clinical predictors of abnormal hysteroscopic findings in women with abnormal uterine bleeding.
349. Association of endometrial thickness with hysteroscopic abnormalities in perimenopausal women.
350. Comparison of hysteroscopic and histopathological diagnosis in postmenopausal bleeding.
351. Prevalence and characteristics of endometrial polyps among women undergoing hysteroscopy for abnormal uterine bleeding.
352. Association of age, obesity, and menopausal status with endometrial polyps detected at hysteroscopy.
353. Diagnostic accuracy of hysteroscopic impression for endometrial hyperplasia and carcinoma.
354. Factors associated with failed or incomplete office hysteroscopy.
355. Comparison of pain scores during office hysteroscopy according to parity and menopausal status.
356. Association of cervical stenosis with difficulty of hysteroscopy in postmenopausal women.
357. Spectrum of uterine cavity abnormalities detected by hysteroscopy in women with recurrent abnormal uterine bleeding despite normal ultrasonography.
358. Concordance between hysterosalpingography and hysteroscopy for uterine cavity abnormalities in infertile women.
359. Factors associated with operative hysteroscopy requirement after diagnostic hysteroscopy for abnormal uterine bleeding.
360. Immediate complications and predictors of procedural difficulty in diagnostic and operative hysteroscopy: a prospective observational study.

Gynecological Laparoscopy and Minimally Invasive Surgery

361. Spectrum of indications and operative findings in gynecological laparoscopy at a tertiary-care hospital.
362. Factors associated with conversion from laparoscopy to laparotomy in benign gynecological surgery.
363. Comparison of perioperative outcomes of total laparoscopic hysterectomy and abdominal hysterectomy for benign gynecological disease.
364. Comparison of perioperative outcomes of laparoscopic and open ovarian cystectomy for benign ovarian masses.
365. Predictors of prolonged operative time during total laparoscopic hysterectomy.
366. Association of uterine size with operative time and blood loss during total laparoscopic hysterectomy.
367. Comparison of perioperative outcomes of laparoscopic hysterectomy in women with and without previous caesarean delivery.
368. Factors associated with intraoperative adhesions during benign gynecological laparoscopy.
369. Correlation of preoperative ultrasonographic findings with laparoscopic operative findings in adnexal masses.
370. Comparison of clinical and laparoscopic diagnosis in women undergoing surgery for chronic pelvic pain.
371. Predictors of difficult laparoscopic entry in women undergoing benign gynecological surgery.
372. Association of body mass index with perioperative outcomes of laparoscopic gynecological surgery.
373. Comparison of perioperative outcomes of laparoscopic and open myomectomy.
374. Factors associated with blood transfusion during laparoscopic gynecological surgery.
375. Prevalence and predictors of significant pelvic adhesions among women undergoing gynecological laparoscopy.
376. Association of previous abdominal surgery with operative difficulty during gynecological laparoscopy.
377. Comparison of immediate postoperative pain and hospital stay following laparoscopic and open surgery for benign gynecological conditions.
378. Clinical and operative predictors of complications during total laparoscopic hysterectomy.
379. Concordance of preoperative diagnosis and final operative diagnosis in women undergoing gynecological laparoscopy.
380. Pattern and immediate outcomes of laparoscopic management of benign gynecological emergencies: a prospective observational study.

Gynecological Surgery and Hysterectomy

381. Clinical profile and indications for hysterectomy for benign gynecological conditions in a tertiary-care hospital.
382. Correlation between preoperative clinical diagnosis and final histopathological findings in hysterectomy specimens.
383. Comparison of perioperative outcomes of abdominal, vaginal, and laparoscopic hysterectomy for appropriately selected benign gynecological conditions.
384. Factors associated with perioperative blood transfusion among women undergoing hysterectomy.
385. Predictors of prolonged operative time in hysterectomy for benign gynecological disease.
386. Association of previous caesarean delivery with operative difficulty and immediate complications during hysterectomy.
387. Comparison of perioperative outcomes of hysterectomy in obese and non-obese women.
388. Factors associated with bladder injury during hysterectomy for benign gynecological conditions: a case-control study.
389. Correlation of preoperative uterine size with operative blood loss during hysterectomy.
390. Comparison of preoperative ultrasonographic diagnosis with final histopathology in women undergoing hysterectomy for abnormal uterine bleeding.
391. Prevalence and predictors of postoperative anaemia following hysterectomy for benign disease.
392. Factors associated with prolonged hospital stay after hysterectomy for benign gynecological conditions.
393. Comparison of immediate postoperative pain and recovery parameters following vaginal and laparoscopic hysterectomy.
394. Association of pelvic adhesions with perioperative complications during hysterectomy.
395. Frequency and predictors of unexpected histopathological findings in hysterectomy specimens obtained for presumed benign disease.
396. Comparison of perioperative outcomes of hysterectomy for uterine leiomyomas and adenomyosis.
397. Predictors of surgical-site infection after major gynecological surgery: a prospective observational study.
398. Association of preoperative anaemia with perioperative morbidity in women undergoing major gynecological surgery.
399. Factors associated with readmission during the early postoperative period after major benign gynecological surgery: a retrospective observational study.
400. Clinical, operative, and histopathological correlation in women undergoing hysterectomy for benign gynecological indications: a prospective observational study.